Stay updated on IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Removal of the ovarian cancer term and a linked genetics resource from the page's related topics section. This affects topic tagging and cross-references, potentially impacting discoverability for ovarian cancer content.
    Difference
    0.2%
    Check dated 2026-09-06T00:26:15.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    Adds NIH grant/contract note (2018), mentions ovarian cancer and related topics (MedlinePlus Genetics), and updates the site revision to v3.6.6 to reflect a newer release.
    Difference
    0.3%
    Check dated 2026-08-29T23:48:43.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    Related topics links for Ovarian cancer and MedlinePlus Genetics were removed from the page's related topics section, reducing external resource navigation.
    Difference
    0.2%
    Check dated 2026-08-22T22:35:33.000Z thumbnail image
  4. Check
    21 days ago
    No Change Detected
  5. Check
    28 days ago
    Change Detected
    Summary
    Added 'Ovarian cancer' as a keyword/related topic and linked MedlinePlus Genetics, and updated the site release version from v3.6.4 to v3.6.5.
    Difference
    0.2%
    Check dated 2026-08-08T20:26:33.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The ovarian cancer keyword and related topics/MedlinePlus Genetics were removed from the study page, reducing disease-context and access to related resources.
    Difference
    0.2%
    Check dated 2026-08-01T18:35:15.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing the previous v3.6.3, reflecting a new deployment/version of the ClinicalTrials.gov interface.
    Difference
    0.1%
    Check dated 2026-07-25T13:21:03.000Z thumbnail image

Stay in the know with updates to IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.